CardiaTec harnesses human heart multiomics data and computational modelling to develop first-in-class cardiovascular therapies
CardiaTec harnesses human heart multiomics data and computational modelling to develop first-in-class cardiovascular therapies. The company is developing the largest proprietary human cardiac multiomics dataset, enriched with clinical annotations to unlock novel insights into disease biology.